ProCE Banner Activity

Shining a Light on HER2-Low and HER2-Ultralow Metastatic Breast Cancer: A Pathologist’s Guide to Bridging the Diagnostic Gaps

Slideset

Access these engaging slides created by leading pathology and medical oncology experts to learn what HCPs need to know to score HER2 levels and incorporate pathologic procedures to diagnose HER2-low/ultralow metastatic breast cancer as well as how to incorporate HER2-targeted therapies into patient care.

Released: March 21, 2025

Expiration: September 20, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.